Hamster preproglucagon contains the sequence of glucagon and two related peptides
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucagon is a 29-amino acid polypeptide hormone synthesized by the A cells of the endocrine pancreas. Its primary site of action is the liver where it stimulates glycogenolysis, gluconeogenesis and ketogenesis. In mammals, biosynthetic studies have shown that glucagon is derived from a precursor of molecular weight (Mr) approximately 18,000 which is five to six times larger than glucagon. Glucagon-containing polypeptides and immunoreactants of various sizes have also been described from stomach, intestine, brain and salivary gland. Here, we have determined the structure of hamster pancreatic preproglucagon from the sequence of its cDNA. This 180-amino acid precursor contains the sequence of glucagon and two glucagon-like polypeptides arranged in tandem. The precursor also contains the sequences of several non-pancreatic glucagon-containing polypeptides which suggests that, in mammals, both pancreatic and non-pancreatic glucagon and glucagon-containing polypeptides may be derived from a common precursor by tissue-specific processing. We have tentatively identified each of the glucagon-like immunoreactants which have been described with respect to the sequence of proglucagon and have proposed a scheme for the processing of pancreatic proglucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“This highlighted for the first time that supplemental GLP-1R/GIPR co-agonism could greatly outperform GLP-1R mono-agonism, to achieve greater weight loss and elicit further improvements in glucose homeostasis48.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“MAR709 successfully completed Phase 1 clinical trials with good tolerability48,124,125, concomitant with a meaningful reduction in body weight and HbA1c levels in subjects with T2D48,125.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“There are two notable unimolecular GLP-1R/GIPR co-agonist peptides that have been preclinically and clinically most characterized to display enhanced glucose-lowering potential, superior weight loss and appetite suppression, when evaluated with comparable GLP-1R agonists.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
3′ Non-coding region sequences in eukaryotic messenger RNA
Proudfoot, N. J., & Brownlee, G. G. (1976) · Nature · doi:10.1038/263211a0 · Cited by 2,968
Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Beaucage, S. L., & Caruthers, M. H. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90461-7 · Cited by 1,993
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
The sequence 5′-AAUAAA-3′ forms part of the recognition site for polyadenylation of late SV40 mRNAs
Fitzgerald, M. (1981) · Cell · doi:10.1016/0092-8674(81)90521-3 · Cited by 776
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Comb, M., Seeburg, P. H., Adelman, J., Eiden, L., & Herbert, E. (1982) · Nature · doi:10.1038/295663a0 · Cited by 679
Research works printed but not linked: 1
- Unger, R.H. & Orei, L. (eds) Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-Cell (Elsevier, New York, 1981).
Cited by
Items 301–400 of 645
Colwill, M., Povlsen, S., Pollok, R., Patel, K., Goodhand, J., Ahmad, T., & Honap, S. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf167 · Cited by 40
The discovery of glucagon-like peptide 1
Lund, P. K. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.09.001 · Cited by 35
Glucagon-like peptide-1 (7–36) amide as a novel neuropeptide
Blázquez, E., Álvarez, E., Navarro, M. A., Roncero, I., de Fonseca, F. R., Chowen, J. A., & Zueco, J. A. (1998) · Molecular Neurobiology · doi:10.1007/bf02914270 · Cited by 41
“The application of recombinant DNA technology led to the elucidation of the primary structure of proglucagon ( Bell et al., 1983 ) from a variety of species, including humans.”
BackgroundPratt, B. L., & Takahashi, J. S. (1989) · Endocrinology · doi:10.1210/endo-125-5-2375 · Cited by 31
Patzelt, C., & Weber, B. H. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04472.x · Cited by 34
Alsalim, W., Lindgren, O., & Åhrén, B. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13962 · Cited by 30
Yang, J., Lin, Y.-T., Chen, W., Yang, Y., Sun, S., & Chen, S. (2020) · Biology · doi:10.3390/biology9110348 · Cited by 32
“Glucagon-like peptide-1 (GLP-1), an incretin hormone secreted from enteroendocrine L-cells of the small intestine, was first identified in the early 1980s [1].”
BackgroundGut peptides in the treatment of diabetes mellitus
Vahl, T. P., & D’Alessio, D. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.3.177 · Cited by 31
“K-cells are predominantly located in the duodenum and jejunum [52-54], but they are also colocalised with L-cells throughout the upper gut [39].”
BackgroundInfluentialInsulinotropic action of human glicentin in dogs
Ohneda, A., Ohneda, K., Nagsaki, T., & Sasaki, K. (1995) · Metabolism · doi:10.1016/0026-0495(95)90288-0 · Cited by 29
Rochelle, J. M., Watson, M. L., Oakey, R. J., & Seldin, M. F. (1992) · Genomics · doi:10.1016/s0888-7543(05)80278-2 · Cited by 29
Oshima, I., Hirota, M., Ohboshi, C., & Shima, K. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90093-6 · Cited by 28
Processing of prosecretin: isolation of a secretin precursor from porcine intestine.
Gafvelin, G., Jörnvall, H., & Mutt, V. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6781 · Cited by 29
Gastrointestinal Endocrinology
Holst, J. J., Fahrenkrug, J., STADIL, F., & Rehfeld, J. F. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609094558 · Cited by 31
Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
Vaillant, C., & Lund, P. K. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.9.3755450 · Cited by 28
“Porcine glicentin contains the sequence of glucagon with COOH- and NH2-terminal extensions (29) and is homologous with the NH2-terminal region [1-69] of mammalian pancreatic pro-glucagons (16,30).”
BackgroundMetabolic Hormones Modulate Macrophage Inflammatory Responses
Batty, M. J., Chabrier, G., Sheridan, A., & Gage, M. (2021) · Cancers · doi:10.3390/cancers13184661 · Cited by 29
“GLP-1 is expressed in L cells of the small and large intestines [113] and is derived from the proglucagon gene [114].”
BackgroundThe influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man
Robertson, M. D., Livesey, G., Morgan, L., Hampton, S., & Mathers, J. C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610025 · Cited by 28
“The gene encoding proglucagon (PG), the biosynthetic precursor of glucagon, encodes a polypeptide of 160 amino acids (Bell et al. 1983).”
BackgroundGastrointestinal surgery and gut hormones
Aylwin, S. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000152979.05456.b6 · Cited by 28
Walker, F., Nice, E. C., Fabri, L., Moy, F. J., Liu, J. F., Wu, R., Scheraga, H. A., & Burgess, A. W. (1990) · Biochemistry · doi:10.1021/bi00499a009 · Cited by 27
Bendet, N., Scapa, E. F., Cohen, O., Bloch, O., Aharoni, D., Ramot, Y., Weiss, M., Halevi, A., & Rapoport, M. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004839 · Cited by 27
Cwikel, B. J., & Habener, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47928-8 · Cited by 27
Novel extrapancreatic effects of incretin
Yamada, Y., Tsukiyama, K., Sato, T. K., Shimizu, T., Fujita, H., & Narita, T. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12495 · Cited by 27
Upregulation of the brainstem preproglucagon system in the obese Zucker rat
Vrang, N., Larsen, P. J., Jensen, P. B., Lykkegaard, K., Artmann, A., Larsen, L. K., & Tang‐Christensen, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.026 · Cited by 32
Primary structure of glucagon from the gut of the common dogfish (Scyliorhinus canicula)
Conlon, J. M., O'Toole, L., & Thim, L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80011-x · Cited by 25
Glucagon and Related Peptides. Molecular Structure and Biological Specificitya
BATAILLE, D., Blache, P., MERCIER, F., Jarrousse, C., Kervran, A., Dufour, M., Mangeat, P. H., Dubrasquet, M., Mallat, A., Lotersztajn, S., et al. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26980.x · Cited by 28
Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes
Tasyurek, H. M., Altunbaş, H., Balcı, M. K., Griffith, T. S., & Şanlıoğlu, S. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.180 · Cited by 24
“of lentivirus vector expressing GLP-1 The prohormone proglucagon consists of 180 aa that when fragmented become glucagon, GLP-1, GLP-2, glicentin, and oxyntomodulin.(26) Since the use of the preproglucagon transgene in a vector would generate all of these bioactive fragments, gene therapy studies involving GLP-1 are r…”
Nozaki, M., Miyata, K., Oota, Y., Gorbman, A., & Plisetskaya, E. M. (1988) · Cell and Tissue Research · doi:10.1007/bf00222293 · Cited by 25
Biosynthesis of regulatory peptides — evolutionary aspects
Conlon, J. M. (1989) · Springer eBooks · doi:10.1007/978-94-009-0835-2_14 · Cited by 29
Cheng, Z., Chen, J., Zhang, Y., Li, X., Zhang, N., Liu, F., & Jiao, Y. (2024) · Foods · doi:10.3390/foods13040519 · Cited by 25
“Pro-glucagon and PCSK1 are critical genes that determine GLP-1 secretion [65,66], the cleavage of the expression product of the pro-glucagon gene is conducted by PCSK1 protein, and then the corresponding fragment for GLP-1 is generated [67].”
BackgroundBaldissera, F. G. A., & Holst, J. J. (1986) · Diabetologia · doi:10.1007/bf00506540 · Cited by 23
Glucagon-like peptide 2 inhibits ghrelin secretion in humans
Banasch, M., Bulut, K., Hagemann, D., Schrader, H., Holst, J. J., Schmidt, W. E., & Meier, J. J. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.07.009 · Cited by 23
Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene
Koiwai, O., Yasui, Y., Sakai, Y., Watanabe, T., Ishii, K., Yanagihara, S., & Andoh, T. (1993) · Gene · doi:10.1016/0378-1119(93)90331-v · Cited by 23
Distribution and molecular forms of glucagon-like peptide in the dog
Suda, K., Takahashi, H., Fukase, N., Manaka, H., Tominaga, M., & Sasaki, H. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90519-5 · Cited by 23
NICHOLS, R., Lee, T. D., & Andrews, P. (1988) · Endocrinology · doi:10.1210/endo-123-6-2639 · Cited by 23
Hulin, B. (1994) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70018-3 · Cited by 25
Noe, B. D., & Andrews, P. (1986) · Peptides · doi:10.1016/0196-9781(86)90232-9 · Cited by 23
GLP-1-mediated gene therapy approaches for diabetes treatment
Tasyurek, H. M., Altunbaş, H., Canatan, H., Griffith, T. S., & Şanlıoğlu, S. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.7 · Cited by 24
Näslund, E. B., Skogar, S., Efendić, S., & Hellström, P. M. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00054-x · Cited by 25
Ørskov, C., Buhl, T., Rabenhøj, L., Kofod, H., & Holst, J. J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81332-8 · Cited by 22
HOLST, J. J., TOFT-NIELSEN, M.-B., ØRSKOV, C., NAUCK, M., & WILLMS, B. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17549.x · Cited by 21
The Molecular Determinants of Glucagon-like Peptide Secretion by the Intestinal L cell
Brubaker, P. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac159 · Cited by 23
Exenatide: A Novel Approach for Treatment of Type 2 Diabetes
Mikhail, N. E. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000240730.86237.b6 · Cited by 22
Plisetskaya, E. M. (1989) · Springer eBooks · doi:10.1007/978-94-009-0835-2_8 · Cited by 22
Matuszewski, W., Baranowska-Jurkun, A., Stefanowicz-Rutkowska, M. M., Gontarz-Nowak, K., Gątarska, E., & Bandurska-Stankiewicz, E. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040705 · Cited by 23
Bonnet, C., Jarrousse, C., Niel, H., Martínez, J., & BATAILLE, D. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90720-b · Cited by 20
E. Näslund, J. B. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520121133 · Cited by 15
3 The Genetics of Non-insulin-Dependent Diabetes Mellitus
Pillay, T. S., Langlois, W. J., & Olefsky, J. M. (1995) · Advances in genetics · doi:10.1016/s0065-2660(08)60203-5 · Cited by 22
Hirota, M., Hashimoto, M., Hiratsuka, M., Ohboshi, C., Yoshimoto, S., Yano, M., Mizuno, A., & Shima, K. (1990) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(90)90110-f · Cited by 20
Kurtzhals, P., Kreiner, F. F., & Bindra, R. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110881 · Cited by 22
Haque, T. S., Lee, V. G., Riexinger, D., Lei, M., Malmstrom, S. E., Li, X., Han, S., Mapelli, C., Cooper, C. B., Zhang, G., et al. (2010) · Peptides · doi:10.1016/j.peptides.2010.01.008 · Cited by 19
“Glucagon-Like-Peptide-1 (GLP-1) was first identified in 1983 [3,4], and has since become one of the leading subjects of interest for treatment of type 2 diabetes [14].”
Burgess, A. W., & Sizeland, A. M. (1990) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1990.tb01778.x · Cited by 19
Proglucagon-derived peptides: human physiology and therapeutic potential
Gasbjerg, L. S., Nielsen, C. K., Suppli, M. P., Grøndahl, M. F. G., Holst, J. J., Knop, F. K., Jeppesen, P. B., & Lund, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00057.2024 · Cited by 22
Predictors of response to liraglutide in Japanese type 2 diabetes
Toyoda, M., Yokoyama, H., Abe, K., Nakamura, S., & Suzuki, D. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.052 · Cited by 19
“[1] Bell GI, Santerre RF, Mullenbach GT.”
Background9 Hormone production by tumours: Biological and clinical aspects
de Bustros, A., & Baylin, S. B. (1985) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(85)80071-2 · Cited by 18
Glucagon-like immunoreactivity in hypothalamic neurons of the rat
Salazar, I., & Vaillant, C. (1990) · Cell and Tissue Research · doi:10.1007/bf00318677 · Cited by 18
“In the pancreas, glucagon is derived from a peptide precursor, proglucagon, which contains a single glucagon sequence plus two other glucagon-like sequences, glucagon-like peptides I (GLP-I) and II (GLP-II) (Bell et al. 1983; Lopez et al. 1983; Heinrich et al. 1984).”
Identification of Glucagon-Like Peptide-1(7–36) Amide in Rat Brain
Yoshimoto, S., Hirota, M., Ohboshi, C., & Shima, K. (1989) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328902600214 · Cited by 22
Guinea pig pancreatic polypeptide: Structure and pancreatic content
Eng, J., Huang, C., Pan, Y.-C. E., Hulmes, J. D., & Yalow, R. S. (1987) · Peptides · doi:10.1016/0196-9781(87)90181-1 · Cited by 18
Cockle, S. M., & Smyth, D. G. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90004-2 · Cited by 18
Delineating the regulation of energy homeostasis using hypothalamic cell models
Wellhauser, L., Gojska, N. M., & Belsham, D. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.09.001 · Cited by 21
“…several proglucagon-derived peptide (PGDP) products by local prohormone convertases in a tissue-specific manner to generate glucagon, glucagon-like peptide 1 (GLP-1), and GLP-2, among others (Bell et al., 1983; Holst et al., 1994; Philippe et al., 1986; Mojsov et al., 1986; Drucker et al., 1986).”
Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis
Kissow, H. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000132 · Cited by 18
“GLP-1 and GLP-2 are products of the proglucagon gene [7] that is expressed primarily in the a-cells of”
BackgroundResponse of plasma glicentin to fat ingestion in piglets
Ohneda, A., Takahashi, H., & Maruyama, Y. (1987) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(87)80014-1 · Cited by 17
Hirota, M., Shimizu, I., Ohboshi, C., Nishino, T., & Shima, K. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90349-4 · Cited by 18
Effect of catch-up growth after food restriction on the entero-insular axis in rats
Chen, L., Yang, W.-H., Zheng, J., Hu, X., Kong, W., & Zhang, H. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-45 · Cited by 17
“the proglucagon gene[26] and subsequent investigations confirmed that GLP-1 is the most important post-prandial hormone responsible for insulin secretion[27,28].”
BackgroundKnapper, J. M. E., Morgan, L., & Fletcher, J. M. (1996) · Proceedings of The Nutrition Society · doi:10.1079/pns19960030 · Cited by 17
Glucagon-Like Peptide-1(7-37) does not Stimulate either Hepatic Glycogenolysis or Ketogenesis.
Murayama, Y., Kawai, K., Suzuki, S., Ohashi, S., & Yamashita, K. (1990) · Endocrinologia Japonica · doi:10.1507/endocrj1954.37.293 · Cited by 20
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin, B. E., Duffin, K. L., & Konkar, A. A. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2023 · Cited by 17
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
He, X., Zhao, W., Li, P., Zhang, Y., Li, G., Su, H., Lu, B., & Pang, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1483792 · Cited by 21
GLP-1 receptor agonists in the treatment of Type 2 diabetes
Bo, A.-R. (2013) · Diabetes Management · doi:10.2217/dmt.13.41 · Cited by 31
Isolation and chemical characterization of glicentin C‐terminal hexapeptide in porcine pancreas
Yanaihara, C., Matsumoto, T., Hong, Y.-M., & Yanaihara, N. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80840-1 · Cited by 20
Biological activities of catfish glucagon and glucagon-like peptide
Hoosein, N. M., Mahrenholz, A. M., Andrews, P., & Gurd, R. S. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90633-4 · Cited by 16
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 18
Yada, T., Dezaki, K., & Iwasaki, Y. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00168.2025 · Cited by 16
On premises and principles for measurement of gastrointestinal peptide hormones
Albrechtsen, N. J. W., & Rehfeld, J. F. (2021) · Peptides · doi:10.1016/j.peptides.2021.170545 · Cited by 15
Discovery of the GI Effects of GLP-1: An Historical Perspective
Holst, J. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07519-3 · Cited by 15
Logical design of oral glucose ingestion pattern minimizing blood glucose in humans
Fujii, M., Murakami, Y., Karasawa, Y., Sumitomo, Y., Fujita, S., Koyama, M., Uda, S., Kubota, H., Inoue, H., Konishi, K., et al. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0108-1 · Cited by 17
Eissele, R., G�ke, R., Weichardt, U., Fehmann, H. C., Arnold, R., & G�ke, B. (1994) · Cell and Tissue Research · doi:10.1007/bf00343955 · Cited by 16
McKay, D. M., Shaw, C. A., Halton, D. W., Johnston, C. F., Fairweather, I., & Buchanan, K. D. (1990) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(90)90019-6 · Cited by 15
Gut signals for islet hormone release
Ebert, R. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01773.x · Cited by 15
Kenkre, J. S., Tan, T., & Bloom, S. R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.5 · Cited by 17
Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
Hare, K. J. (2010) · PubMed · Cited by 18
Kim, Y., & Rose, C. A. (1995) · Pharmaceutical Research · doi:10.1023/a:1016209304172 · Cited by 14
“KEY WORDS: insulinotropin (glucagon-like peptide I-(7-37)); protamine; phenol; zinc; isophane ratio.”
BackgroundMethodGlicentin is present in the pig pancreas
Sheikh, S. P., Baldissera, F. G. A., Karlsen, F. Ø., & Holst, J. J. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80178-2 · Cited by 14
Endocrine pancreas of teleost fish: A model for interaction of islet hormones?
Plisetskaya, E. M. (1990) · Journal of Experimental Zoology · doi:10.1002/jez.1402560410 · Cited by 14
INTRACELLULAR PROTEOLYTIC MECHANISMS IN THE BIOSYNTHESIS OF HORMONES AND PEPTIDE NEUROTRANSMITTERS
Steiner, D. F., Docherty, K., Chan, S. J., Segundo, B. S., & Carroll, R. (1983) · Elsevier eBooks · doi:10.1016/b978-0-12-417320-0.50006-8 · Cited by 14
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 15
Plasma glicentin in diabetic and gastrectomized patients
Naito, H., Ohneda, A., Kojima, R., Sato, T., Sasaki, K., Funayama, Y., Fukushima, K., Shibata, C., Matsuno, S., & Sasaki, I. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00144-x · Cited by 13
Therapeutic potential of spinal GLP-1 receptor signaling
Zhang, D., & Lv, G. (2018) · Peptides · doi:10.1016/j.peptides.2018.01.003 · Cited by 13
Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes
Ebinger, M., Jehle, D. R., Fussgaenger, R. D., Fehmann, H. C., & Jehle, P. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e88 · Cited by 13
Gut peptide hormones: Importance for food intake
Näslund, E. B., Schmidt, P. T., & Hellström, P. M. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410010634 · Cited by 13
“[53] Bell GI, Santerre RF, Mullenbach GT.”
BackgroundHaque, T. S., Martinez, R. L., Lee, V. G., Riexinger, D., Lei, M., Feng, M., Koplowitz, B., Mapelli, C., Cooper, C. B., Zhang, G., et al. (2010) · Peptides · doi:10.1016/j.peptides.2010.04.013 · Cited by 13
Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs
Ohneda, A., Kobayashi, T., & Nihei, J. (1986) · Diabetologia · doi:10.1007/bf00903352 · Cited by 13
“Glicentin has been known not only as a component of gut glucagon-like immunoreactivity (GLI) [1], but also as a precursor of pancreatic glucagon [2, 3].”
BackgroundMutational Landscape of the Proglucagon-Derived Peptides
Lindquist, P., Madsen, J. S., Bräuner‐Osborne, H., ROSENKILDE, M. M., & Hauser, A. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.698511 · Cited by 14
“In the early 1980s proglucagon amino acid sequences were first determined from anglerfish isolates, followed by hamster and human cDNAs, which revealed that glucagon and two related glucagon-like peptide (GLP) hormones were derived from a larger preprohormone (1, 2).”
BackgroundEnteroglucagon, bowel growth and GLP-2
Dunphy, J. L., & Fuller, P. J. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00137-8 · Cited by 13
Fehmann, H. C., Strowski, M. Z., & Göke, B. (1994) · Metabolism · doi:10.1016/0026-0495(94)90132-5 · Cited by 16
Ooi, A., Katsuda, S., Nakanishi, I., Kameya, T., Aamaguchi, K., Kitamura, H., & Hayakawa, Y. (1989) · Ultrastructural Pathology · doi:10.3109/01913128909051156 · Cited by 13
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
Li, S., Huang, N., Wang, M., Huang, W., Luo, Y., & Huang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610512 · Cited by 21
“In 1983, Bell et al. con fi rmed that GLP-1 was cleaved from proglucagon in the gut by cloning and sequencing the mammalian glucagon gene (Bell et al., 1983a; Bell et al., 1983b).”
Zhang, J., Sanan, S., Csanalosi, M., Zheng, C., & Pfeiffer, A. F. H. (2025) · Endocrinology · doi:10.1210/endocr/bqaf130 · Cited by 15
Ali, A., Flatt, P. R., & Irwin, N. (2024) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514241238059 · Cited by 13
“67 Similar to other endogenous regulatory peptides, GLP-2 has a short biological half-life and is readily broken down in the circulation by the enzyme DPP-4, to yield and inactive peptide metabolite.”
BackgroundGastrointestinal hormone research – with a Scandinavian annotation
Rehfeld, J. F. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1025831 · Cited by 12
“Second, gene cloning and sequencing have revealed new gut hormones, for instance GLP-1 and -2, expressed by the glucagon gene [32], and obestatin, expressed by the ghrelin gene.”
BackgroundFang, Y., Liu, X., Zhao, L., Wei, Z., Jiang, D., Shao, H., Zang, Y., Xu, J., Wang, Q., Liu, Y., et al. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.5.475 · Cited by 13
Metadata
- Authors
- Bell, G. I., Santerre, R. F., & Mullenbach, G. T.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1983-04
- Volume
- 302
- Issue
- 5910
- Pages
- 716-718
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061274996
- Cited by
- 649
- References
- 35
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 9 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 16 · 2018: 16 · 2017: 8 · 2016: 18 · 2015: 13 · 2014: 21 · 2013: 12 · 2012: 9
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proglucagon, glucagon, hamster, pancreatic A cells, cDNA sequence, precursor processing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Fishes, Glucagon, Cricetinae, Molecular Weight, Protein Precursors, RNA, Messenger, Species Specificity, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.